News Oct 16, 2020 Polyphor receives up to 18 million dollars for development of antibiotics The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Po...
News Sep 01, 2020 Polyphor awarded exclusive licensing agreement for China The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in China. Fosun Pharma will lead clinical dev...
Expertise Aug 26, 2020 The potential positive economic and climate impacts of a more Circular Economy How can circular economy provide a model that enables our economies to grow while maintaining our planetary boundaries? Let us present a brief su...
Actualités Jan 30, 2018 La Suisse reste numéro un mondiale de l’innovation La Suisse obtient toujours d’excellentes notes en matière d’innovation. Une fois de plus, elle a été désignée pays le plus innovant au monde, cet...
Success stories May 25, 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
Aktuell May 22, 2017 Clariant fusioniert mit Huntsman Das Spezialchemieunternehmen Clariant hat sich mit der US-Chemiefirma Huntsman auf eine gleichberechtigte Fusion geeinigt. Der internationale Hau...
Success stories Aug 20, 2017 Suisselle Sarl: With an eye to the whole world Suisselle Sàrl Suisselle is engaged in the production of fillers and injections for mesotherapy, which are used in beauty medicine and therapeutic cosmetology. ...
Aktuell Jan 30, 2018 Polyphor entwickelt inhalative Antibiotika Das Pharmaunternehmen Polyphor will sein neuartiges Antibiotikum Murepavadin auch über die Atemwege verabreichen. Dazu wird ein grossangelegtes F...
Actualités Jan 30, 2018 Merck inaugure son nouveau centre de conditionnement en Suisse Merck, société allemande leader en sciences et technologies, a inauguré à Aubonne un nouveau bâtiment qui fera office de centre de conditionnemen...
Actualités Jan 30, 2018 Merck crée une société de R&D à Genève Créée par Merck Ventures, le fonds de capital-risque du géant allemand, iOnctura est une nouvelle société spécialisée dans l’immuno-oncologie.
Press Release Jan 30, 2024 Exports stagnant: Swiss companies adjust their expectations and strategies Swiss SMEs are still expecting minimal export growth in the coming months. This is the finding of the latest survey of Swiss SMEs conducted by Sw...
News Oct 29, 2019 Dutch chemicals group DSM expands Valais facility The global leader in vitamin development and manufacturing DSM has announced an investment of 55 million Swiss francs in its production facility ...
ニュース Jul 24, 2017 2017年上半期、日本企業によるM&Aが相次ぐ 2017年上半期は、日本企業によるスイス企業の買収が相次いで発表されました。企業価値の向上や既存事業の拡充など、世界規模で活動する日本企業の更なるグローバル展開の礎として、スイスの認知の高まりを見せています。
Global Opportunities Jun 03, 2020 The Pharmaceutical Sector in Ireland: Opportunities for Swiss companies As cornerstones of the Irish economy, the pharma and life sciences sectors have contributed vastly to the attractiveness of Ireland to foreign co...
ニュース Jan 30, 2018 メルクがスイスでパッケージングセンターを新設 世界有数のサイエンス・テクノロジー企業であるメルク(本社:ドイツ・ダルムシュタット)が、ヴォー州・オボンヌで医薬品パッケージングセンターを開業しました。新施設はメルク社が提供するバイオテクノロジー製品の開発における長期的な需要に応える設備を備えています。
News Sep 19, 2018 Alcon to move global headquarters to Geneva Alcon, the global leader in eye care and a division of Novartis, has announced plans to locate its future global headquarters in the Canton of Ge...